发明申请
- 专利标题： Transdermal atomoxetine formulations and associated methods
- 专利标题（中）： 透皮阿托西汀制剂及相关方法
-
申请号： US11499912申请日： 2006-08-04
-
公开(公告)号： US20080031932A1公开(公告)日： 2008-02-07
- 发明人: Kamal K. Midha
- 申请人： Kamal K. Midha
- 申请人地址： US UT Salt Lake City
- 专利权人： Watson Laboratories, Inc.
- 当前专利权人： Watson Laboratories, Inc.
- 当前专利权人地址： US UT Salt Lake City
- 主分类号： A61K31/138
- IPC分类号： A61K31/138 ; A61K9/70
摘要：
Methods and formulations for delivering atomoxetine compounds that minimize drug metabolism and thus increase the effectiveness of the drug are disclosed. The method may include maximizing the in vivo potency of an atomoxetine compound in a subject by transdermally administering the atomoxetine compound to the subject. The in vivo potency of the atomoxetine compound may be maximized by minimizing the in vivo conversion of the atomoxetine compound to an atomoxetine compound metabolite.
信息查询
IPC分类:
